Tag: Prescription Drugs
In Utero Antipsychotic Exposure May Not Up Neurodevelopmental Disorder Risk
Commonly prescribed antipsychotic medications taken late in pregnancy seem not to meaningfully increase NDD risk in offspring
GLP-1 RA Use May Up Risk for Gallbladder, Biliary Diseases
GLP-1 RA treatment linked to increased risk, especially in trials for weight loss, and with higher doses and longer duration of use
ED-Initiated Buprenorphine for OUD Often Not Sustained
Many patients filling buprenorphine prescriptions written by emergency physicians do not subsequently fill prescriptions for the treatment
FDA Advisory Panel Narrowly Votes Against New ALS Drug
Panelists said they hoped results of a larger study, now underway, would provide more evidence on the drug
Preconception Paternal Metformin Linked to Major Birth Defects
Genital birth defects, all in boys, more common among metformin-exposed offspring
Use of Medications for Opioid Use Disorder Low
Past-year use lowest for adolescents and adults aged 50 years and older
FDA Reviewers Give Thumbs Down to New ALS Drug
Agency said results were 'not persuasive,' citing missing data, mistakes in enlisting patients, other issues
Risk for Ischemic Stroke Up With Antidopaminergic Antiemetic Use
Increase in risk greatest for metopimazine and metoclopramide; risk for ischemic stroke may be higher in first days of use
AAD: Baricitinib Tops Placebo for Hair Regrowth in Alopecia Areata
In two phase 3 trials, baricitinib superior to placebo in terms of percentage of patients with a SALT score of 20 or less at week 36
Stakes Are High Ahead of FDA Panel Vote on ALS Drug
AMX0035 is a combination of two established drug ingredients -- sodium phenylbutyrate and taurursodiol
